Cannabis firm shares reversed early gains after the US government's marijuana reclassification proved limited to FDA-approved and state-licensed medical products, falling short of the broader policy investors had anticipated.
#News #Reuters #Newsfeed #marijuananews #medicalmarijuanapatient #usa #medicine #pharma
Read the story here: https://reut.rs/42qCyl6
š Subscribe: https://reut.rs/4b8fRGn
Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on X: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Trump administration reclassifies medical marijuana
- Reclassifying marijuana as a less dangerous drug might only be the first step for Trump ABC News —
- Medical marijuana has been reclassified. Is recreational pot next? Associated Press —
- Trump reclassifies state-licensed medical marijuana as a less-dangerous drug Times Of India —
- Government recategorizes marijuana to a lower drug classification CBS News —
- US reclassifies marijuana as less harmful substance Semafor —
Pot firms reverse gains on narrow scope of US rescheduling
Reuters
—